1. Home
  2. IMMP vs COE Comparison

IMMP vs COE Comparison

Compare IMMP & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • COE
  • Stock Information
  • Founded
  • IMMP 1987
  • COE 2011
  • Country
  • IMMP Australia
  • COE Singapore
  • Employees
  • IMMP N/A
  • COE N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • COE Other Consumer Services
  • Sector
  • IMMP Health Care
  • COE Real Estate
  • Exchange
  • IMMP Nasdaq
  • COE Nasdaq
  • Market Cap
  • IMMP 251.8M
  • COE 271.9M
  • IPO Year
  • IMMP N/A
  • COE 2016
  • Fundamental
  • Price
  • IMMP $1.64
  • COE $47.79
  • Analyst Decision
  • IMMP Buy
  • COE
  • Analyst Count
  • IMMP 1
  • COE 0
  • Target Price
  • IMMP $7.00
  • COE N/A
  • AVG Volume (30 Days)
  • IMMP 87.8K
  • COE 17.1K
  • Earning Date
  • IMMP 10-21-2025
  • COE 09-03-2025
  • Dividend Yield
  • IMMP N/A
  • COE N/A
  • EPS Growth
  • IMMP N/A
  • COE N/A
  • EPS
  • IMMP N/A
  • COE N/A
  • Revenue
  • IMMP $3,306,742.00
  • COE $68,928,000.00
  • Revenue This Year
  • IMMP N/A
  • COE N/A
  • Revenue Next Year
  • IMMP $725.37
  • COE N/A
  • P/E Ratio
  • IMMP N/A
  • COE N/A
  • Revenue Growth
  • IMMP 31.28
  • COE 93.05
  • 52 Week Low
  • IMMP $1.32
  • COE $12.98
  • 52 Week High
  • IMMP $2.71
  • COE $51.71
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 46.06
  • COE 75.45
  • Support Level
  • IMMP $1.60
  • COE $45.70
  • Resistance Level
  • IMMP $1.68
  • COE $51.71
  • Average True Range (ATR)
  • IMMP 0.07
  • COE 3.24
  • MACD
  • IMMP -0.00
  • COE 0.89
  • Stochastic Oscillator
  • IMMP 28.12
  • COE 78.61

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.

Share on Social Networks: